These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7523815)
61. Concomitant use of thioridazine with risperidone. Goss JB Am J Health Syst Pharm; 1995 May; 52(9):1012. PubMed ID: 7543812 [No Abstract] [Full Text] [Related]
62. A case of delayed NMS induced by risperidone. Lee MS; Lee HJ; Kim L Psychiatr Serv; 2000 Feb; 51(2):254-5. PubMed ID: 10655017 [No Abstract] [Full Text] [Related]
63. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. Hasan S; Buckley P Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705 [TBL] [Abstract][Full Text] [Related]
64. Adverse reaction reporting and new antipsychotics. Kerwin R Lancet; 1993 Dec; 342(8885):1440. PubMed ID: 7504153 [No Abstract] [Full Text] [Related]
65. Neuroleptic malignant syndrome in the burns patient? Cawrse N; Wilson S; Williams M; Burge T Burns; 2006 Aug; 32(5):647-9. PubMed ID: 16777336 [No Abstract] [Full Text] [Related]
66. Risperidone: integrating research and practice. Addington D Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628 [TBL] [Abstract][Full Text] [Related]
67. Risperidone for chronic schizophrenia. Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777 [No Abstract] [Full Text] [Related]
68. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741 [TBL] [Abstract][Full Text] [Related]
69. Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective. Menkes DB BMJ; 1993 Jul; 307(6897):200. PubMed ID: 7688254 [No Abstract] [Full Text] [Related]
70. Neuroleptic malignant syndrome and risperidone: a case report. Bonwick RJ; Hopwood MJ; Morris PL Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956 [TBL] [Abstract][Full Text] [Related]
71. Recent developments in antipsychotic therapy. Introduction. Love RC Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S3-4. PubMed ID: 7538436 [No Abstract] [Full Text] [Related]
73. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report. Mall GD; Hake L; Benjamin AB; Adityanjee A J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658 [No Abstract] [Full Text] [Related]
74. Schizophrenia and severe tardive dyskinesia responsive to risperidone. Kopala LC; Honer WG J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794 [No Abstract] [Full Text] [Related]
75. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone. van der Linden C; Bruggeman R; van Woerkom TC Mov Disord; 1994 Nov; 9(6):687-8. PubMed ID: 7531282 [No Abstract] [Full Text] [Related]
77. Clinical review of risperidone. Chouinard G; Arnott W Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574 [TBL] [Abstract][Full Text] [Related]
78. [Neuroleptic malignant syndrome induced by risperidone]. Rohrbach P; Collinot JP; Vallet G Ann Fr Anesth Reanim; 1998; 17(1):85-6. PubMed ID: 9750694 [No Abstract] [Full Text] [Related]
79. New drug offers hope for people with schizophrenia. J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676 [No Abstract] [Full Text] [Related]
80. Neuroleptic malignant syndrome during a change from haloperidol to risperidone. Reeves RR; Mack JE; Torres RA Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]